Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
0 hedge funds and large institutions have $0 invested in Gritstone bio, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
100% less funds holding
Funds holding: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $773 → $0 (-$773)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$751 |
| 2 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
-$22 |
GRTS Hedge Fund Activity: Q1 2025 in Review
0 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q1 2025, worth a combined $0 — down 100% from $773 a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of GRTS and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Baader Bank Aktiengesellschaft, exiting entirely with an estimated $751 sold.
- 0 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q1 2025, down from 6 in Q4 2024.
- Funds reported $0 of Gritstone bio, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
- 0 funds opened new Gritstone bio, Inc. Common Stock positions in Q1 2025 and 6 closed out, a net change of -6 holders.
- The largest Gritstone bio, Inc. Common Stock seller in Q1 2025 was Baader Bank Aktiengesellschaft, an estimated $751 sold.
Based on aggregated 13F filings for Q1 2025.